Milestone Pharmaceuticals: Q1 Earnings Snapshot
The Montreal-based company said it had a loss of 31 cents per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
_____
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
22 minutes ago
- San Francisco Chronicle
Allogene Therapeutics: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Wednesday reported a loss of $50.9 million in its second quarter. The South San Francisco, California-based company said it had a loss of 23 cents per share. The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share. In the final minutes of trading on Wednesday, the company's shares hit $1.05. A year ago, they were trading at $2.35. _____
San Francisco Chronicle
22 minutes ago
- San Francisco Chronicle
Crescent Capital BDC: Q2 Earnings Snapshot
LOS ANGELES (AP) — LOS ANGELES (AP) — Crescent Capital BDC, Inc. (CCAP) on Wednesday reported second-quarter earnings of $15 million. On a per-share basis, the Los Angeles-based company said it had profit of 41 cents. Earnings, adjusted for investment costs, came to 46 cents per share. The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for earnings of 46 cents per share. The company posted revenue of $43 million in the period. _____
San Francisco Chronicle
22 minutes ago
- San Francisco Chronicle
Boston Omaha: Q2 Earnings Snapshot
OMAHA, Neb. (AP) — OMAHA, Neb. (AP) — Boston Omaha Corp. (BOC) on Wednesday reported a loss of $2.3 million in its second quarter. On a per-share basis, the Omaha, Nebraska-based company said it had a loss of 7 cents. The provider of real estate and business consulting services posted revenue of $28.2 million in the period. Boston Omaha shares have fallen 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $13.72, a climb of 2% in the last 12 months. _____
